Increased DNA polymerase fidelity of the lamivudine resistant variants of human hepatitis B virus DNA polymerase

Journal of Biochemistry and Molecular Biology

Volumn 37, Issue 2, 2004, Pages 167-176

  Hong, Young Bin ^a   Choi, Yongwook ^b   Jung, Guhung ^b  

^a Korea National Institute of Health   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Fidelity; HBV polymerase; Lamivudine; Met550 variants

Indexed keywords

DNA POLYMERASE; EXONUCLEASE; LAMIVUDINE; METHIONINE; NUCLEOTIDE; TRANSCRIPTASE; VIRUS DNA; VIRUS ENZYME;

ANTIBIOTIC RESISTANCE; ARTICLE; ENZYME ACTIVITY; ENZYME PURIFICATION; EVALUATION; HEPATITIS B VIRUS; HUMAN; INSECT CELL; NONHUMAN; WILD TYPE;

DNA VIRUSES; HEPATITIS B VIRUS; INSECTA;

EID: 2342488635     PISSN: 12258687     EISSN: None     Source Type: Journal    
DOI: 10.5483/bmbrep.2004.37.2.167     Document Type: Article

References (38)

1. Allen, M. I., Deslauriers, M., Andrew, C. W., Tipple, G. A., Walters, K. A., Tyrrell, D. L., Brown, N. and Condreay, L. D. (1998) Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 27, 1670-1677.
2. Bakhanashvili, M., Avidan, O. and Hizi, A. (1996) Mutational studies of human immunodeficiency virus type 1 reverse transcriptase: the involvement of residues 183 and 184 in the fidelity of DNA synthesis. FEBS Lett. 391, 257-262.
3. Bartholomew, M. M., Jansen, R. W., Jeffers, L. J., Reddy, K. R., Johnson, L. C., Bunzendahl, H., Condreay, L. D., Tzakis, A. G., Schiff, E. R. and Brown, N. A. (1997) Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 349, 20-22.
4. Beasley, R. P., Hwang, L. Y., Lin, C. C. and Chien, C. S. (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 2, 1129-1133.
5. Boosalis, M. S., Petruska, J. and Goodman, M. F. (1987) DNA polymerase insertion fidelity. Gel assay for site-specific kinetics. J. Biol. Chem. 262, 14689-14696.
6. Buti, M., Jardi, R., Cotrina, M., Rodirquez-Frias, F, Esteban, R. and Guardia, J. (1998) Transient emergence of hepatitis B variants in a patient with chronic hepatitis B resistant to lamivudine. J. Hepatol 28, 510-513.
7. Coates, J. A., Cammack, N., Jenkinson, H. J., Jowett, A. J., Jowett, M. I., Pearson, B. A., Penn, C. R., Rouse, P. L., Viner, K. C. and Cameron, J. M. (1992) (-)-2′-deoxy-3′-thiacytinine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro. Antimicrob. Agents Chemother. 36, 733-739.
8. Das, K., Xiong, X., Yang, H., Westland, C. E., Gibbs, C. S., Sarafianos, S. G. and Arnold, E. (2001) Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to Lamivudine(3TC) and Emtricitabine(FTC). J. Virol. 75, 4771-4779.
9. De Clercq, E. (1999) Perspectives for the treatment of hepatitis B virus infections. Int. J. Antimicrob. Agents 12, 81-95.
10. Dienstag, J. L., Schiff, R., Wright, T. L., Perrillo, R. P., Hann, H. W., Goodman, Z., Crowther, L., Condreay, L. D., Woessner, M., Rubin, M. and Brown, N. A. (1999) Lamivudine as initial treatment for chronic hepatitis B in the United States. N. Engl. J. Med. 341, 1256-1263.
11. Echols, H. and Goodman, M. F. (1991) Fidelity mechanisms in DNA replication. Annu. Rev. Biochem. 60, 477-511.
12. Hamburgh, M. E., Drosopoulos, W. C. and Prasad, V. R. (1998) The influence of 3TC resistance mutations E89G and M184V in the human immunodeficiency virus reverse transcriptase on mispair extension efficiency. Nucleic Acid Res. 26, 4389-4394.
13. Harrison, T. J. (1996) Genetic variation in hepatitis B virus. Eur. J. Gastroenterol. Hepatol. 8, 306-311.
14. Hubner, A., Kruhoffer, M., Grosse, F. and Krauss, G. (1992) Fidelity of human immunodeficiency virus type I reverse transcriptase in copying natural RNA. J. Mol. Biol. 223, 595-600.
15. Jacobo-Molina, A., Ding, J., Nanni, R. G., Clark, A. D., Lu, X. Jr., Tantillo, C., Williams, R. L., Kamer, G., Ferris, A. L., Clark, P., Hizi, A., Hughes, S. H. and Arnold, E. (1993) Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0Å resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90, 6320-6324.
16. Jardi, R., Buti, M., Rodriguez-Frias, F., Cotrina, M., Costa, X., Pascual, C., Esteban, R. and Guardia, J. (1999) Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants. J. Virol. Methods 83, 181-187.
17. Jarvis, B. and Faulds, D. (1999) Lamivudine. A review of its therapeutic potential in chronic hepatitis B. Drugs 58, 101-141.
18. Kaushik, N., Chowdhury, K., Pandey, V. N. and Modak, M. J. (2000) Valine of the YVDD motif of moloney murine leukemia virus reverse transcriptase: role in the fidelity of DNA synthesis. Biochemistry 39, 5155-5165.
19. 1 of Acinetobacter lwoffii K24. J. Biochem. Mol. Biol. 34, 172-175.
20. Kunkel, T. A. (1992) DNA replication fidelity. J. Biol. Chem. 267, 18251-18254.
21. Lai, C. L., Chien, R. N., Leung, N. W., Chang, T. T., Guan, R., Tai, D. I., Ng, K. Y., Wu, P. C., Dent, J. C., Barber, J., Stephenson, S. L. and Gray, D. F. (1998) A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N. Engl. J. Med. 339, 61-69.
22. Ling, R., Mutimer, D., Ahmed, M., Boxall, E. H., Elias, E., Dusheiko, G. M. and Harrison, T. J. (1996) Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 24, 711-713.
23. Lok, A. S. (2000) Hepatitis B infection: pathogenesis and management. J. Hepatol. 32, 89-97.
24. Mendelman, L. V., Boosalis, M. S., Petruska, J. and Goodman, M. F. (1989) Nearest neighbor influences on DNA polymerase insertion fidelity. J. Biol. Chem. 264, 14415-14423.
25. Mendelman, L. V., Petruska, J. and Goodman, M. F. (1990) Base mispair extension kinetics. Comparison of DNA polymerase alpha and reverse transcriptase. J. Biol. Chem. 265, 2338-2346.
26. Ono, S. K., Kato, N., Shiratori, Y., Kato, J., Goto, T., Schinazi, R. F., Carrilho, F. J. and Omata, M. (2001) The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance. J. Clin. Invest. 107, 449-455.
27. Oude Essink, B. B., Back, N. K. and Berkhout, B. (1997) Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase. Nucleic Acids Res. 25, 3212-3217.
28. Pandey, V. N., Kaushik, N., Rege, N., Sarafianos, S. G., Yandav, P. N. and Modak, M. J. (1996) Role of methionine 184 of human immunodeficiency virus type-1 reverse transcriptase in the polymerase function and fidelity of DNA synthesis. Biochemistry 35, 2168-2179.
29. Park, S. G. and Jung, G. (2001) Human hepatitis B virus polymerase interacts with the molecular chaperonin Hsp60. J. Virol. 75, 6962-6968.
30. Park, I. and David, J. I. (2002) Mutations within the putative active site of heterodimeric deoxyguanosine kinase block the allosteric activation of the deoxyadenosine kinase subunit. J. Biochem. Mol. Biol. 35, 244-247.
31. Preston, B. D., Poiesz, B. J. and Loeb, L. A. (1988) Fidelity of HIV-1 reverse transcriptase. Science 242, 1168-1171.
32. Randall, S. K., Eritja, R., Kaplan, B. E., Petruska, J. and Goodman, M. F. (1987) Nucleotide insertion kinetics opposite abasic lesions in DNA. J. Biol. Chem. 262, 6864-6870.
33. Rho, H. M., Kim, K., Hyun, S. W. and Kim, Y. S. (1989) The nucleotide sequence and reading frames of a mutant hepatitis B virus subtype adr. Nucleic Acids Res. 17, 21-24.
34. Santantonio, T., Mazzola, M., Iacovazzi, T., Miglietta, A., Guastadisegni, A. and Pastore, G. (2000) Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine. J. Hepatol. 32, 300-306.
35. Schuurman, R., Nijhuis, M., van Leeuwen, R., Schipper, P., de Jong, D., Collis, P., Danner, S. A., Mulder, J., Loveday, C. and Christopherson, C., et al. (1995) Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). J. Infect. Dis. 171, 1411-1419.
36. Williams, K. J. and Loeb, L. A. (1992) Retroviral reverse transcriptases: error frequencies and mutagenesis. Curr. Top. Microbiol. Immunol. 176, 165-180.
37. Yu, H. and Goodman, M. F. (1992) Comparison of HIV-1 and avian myeloblastosis virus reverse transcriptase fidelity on RNA and DNA templates. J. Biol. Chem. 267, 10888-10896.
38. Zoulim, F. (1999) Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies. Antiviral. Res. 44, 1-30.